March 16, 2020 / 10:43 PM / 19 days ago

BRIEF-Oncternal Announces Q4 2019 Financial Results

March 16 (Reuters) - Oncternal Therapeutics Inc:

* ONCTERNAL PROVIDES BUSINESS UPDATE AND ANNOUNCES FOURTH QUARTER AND FULL YEAR 2019 FINANCIAL RESULTS

* Q4 LOSS PER SHARE $0.27

* Q4 REVENUE $700,000 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below